Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04496687
Other study ID # 20190308
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 8, 2019
Est. completion date December 31, 2025

Study information

Verified date August 2023
Source SCAD Alliance
Contact Esther Kim, MD, MPH
Phone 704-373-0212
Email Soo.Kim@atriumhealth.org
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD. The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.


Description:

Spontaneous Coronary Artery Dissection (SCAD) is an under-diagnosed cause of acute coronary syndrome (ACS), myocardial infarction (MI) and sudden cardiac arrest. The inner lining of the coronary artery splits and allows blood to seep into the adjacent layer, forming a blockage (hematoma), or the artery continues to tear, creating a flap of tissue that blocks blood flow in the artery. SCAD strikes generally healthy, younger individuals (average age 42) who do not have traditional cardiac risk factors. Warning signs of SCAD encompass the full range of ACS and MI symptoms, from vague to classic. The cause of SCAD is currently unknown and the psychosocial impact of SCAD is traumatizing. The work of the iSCAD Registry will encompass the physical and psychosocial study of SCAD.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Participants with a new diagnosis of SCAD or a history of confirmed or suspected SCAD will be prospectively recruited from either: 1. Inpatient wards of the enrolling medical centers during the acute presentation of SCAD, or 2. Outpatient cardiovascular clinics of enrolling medical centers. Participants must be: - 18 years of age or older - Diagnosis of SCAD or history of SCAD based on coronary angiography, either catheter-based or coronary CTA - Suspected SCAD by coronary angiography Exclusion Criteria: 1. Coronary dissection in association with atherosclerosis or as a result of iatrogenic injury 2. Inability to provide informed consent 3. Inability to complete study-related patient questionnaires 4. Inability to understand and complete patient questionnaires independently

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Australia Victor Chang Cardiac Research Institute Darlinghurst New South Wales
United States Emory Healthcare System Atlanta Georgia
United States University of Colorado Aurora Colorado
United States Johns Hopkins Baltimore Maryland
United States Massachusetts General Hospital Boston Massachusetts
United States Atrium Health Sanger Heart and Vascular Institute Charlotte North Carolina
United States University of Virginia Charlottesville Virginia
United States University Hospitals--Case Western Cleveland Ohio
United States UT Southwestern Dallas Texas
United States Hartford Hospital Hartford Connecticut
United States St. Luke's Mid America Kansas City Missouri
United States Dartmouth-Hitchcock Lebanon New Hampshire
United States University of Kentucky Lexington Kentucky
United States UCLA (University of California, Los Angeles) Los Angeles California
United States Catholic Medical Center Manchester New Hampshire
United States Intermountain Murray Utah
United States Vanderbilt University Medical Center Nashville Tennessee
United States Columbia University Medical Center New York New York
United States Mount Sinai New York New York
United States Oklahoma Heart Oklahoma City Oklahoma
United States University of Pennsylvania Philadelphia Pennsylvania
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania
United States Providence Portland Oregon
United States Washington University Saint Louis Missouri
United States Kaiser Permanente Northern California San Francisco California
United States University of South Florida Tampa Florida

Sponsors (2)

Lead Sponsor Collaborator
SCAD Alliance PERFUSE Study Group

Countries where clinical trial is conducted

United States,  Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Descriptive Data Participant demographic, historical, clinical characteristics, and treatment data Continuous time frame following index event for an average of 3 years from study contact date
Primary Clinical Outcomes Prospectively collected long-term outcomes including recurrent myocardial infarction, hospitalization, heart failure, stroke or transient ischemic attack, arrhythmia, and all cause mortality Continuous time frame following index event for an average of 3 years from study contact date
Primary Psychosocial Outcomes Prospectively collected data on participant's mental health using validated questionnaires Continuous time frame following index event for an average of 3 years from study contact date
See also
  Status Clinical Trial Phase
Recruiting NCT01967511 - Defining the Basis of Fibromuscular Dysplasia (FMD)
Enrolling by invitation NCT03876847 - Genetics of Spontaneous Coronary Artery Dissection (SCAD-INSPIRE Genetics)
Completed NCT03390998 - Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD
Completed NCT02799186 - The Study of the Prevalence Fibromuscular Dysplasia in Patient With Haematoma or Spontaneous Coronary Artery Dissection. N/A
Enrolling by invitation NCT01427179 - Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
Active, not recruiting NCT02188069 - Canadian SCAD Study
Recruiting NCT06323811 - Comparison of Free-breathing 3D Quantitative Perfusion in Patients With MINOCA and MINOCA-mimics N/A
Recruiting NCT05699200 - A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection N/A
Recruiting NCT01429727 - The "Virtual" Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry
Recruiting NCT03607981 - Spanish Registry on Spontaneous Coronary Artery Dissection
Completed NCT04415762 - Spontaneous Coronary Artery Dissection Registry (DIssezioni Spontanee COronariche ITalian-SPAnish)
Recruiting NCT04906356 - Canadian SCAD Study
Recruiting NCT04457544 - Spontaneous Coronary Artery Dissection National Swiss Registry
Not yet recruiting NCT04850417 - Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection Phase 4
Withdrawn NCT03335020 - Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease Phase 1